T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Marco Ruella, Luca Paruzzo et al.|Nature Medicine|2024Cited by 254
Bendamustine lymphodepletion before axicabtagene ciloleucel is safe and associates with reduced inflammatory cytokinesGuido Ghilardi, Marco Ruella, Luca Paruzzo et al.|Blood Advances|2023Cited by 30
Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucelGuido Ghilardi, Marco Ruella, Luca Paruzzo et al.|Journal of Hematology & Oncology|2024Cited by 8